Director, ORDA 
3 
January 2l , 1982 
a major error. We recognize that a continuation of the 
Guidelines is expensive. Abolition of the Guidelines (i.e., 
the December 4 RAC proposal) may, however, in the long run be 
even more expensive, by inviting multiple conflicting state 
and local regulations, or by inviting a backlash of mistrust 
and revulsion if public health hazards are eventually associated 
with the use of recombinant DNA in the future. 
Sincerely yours. 
Cambridge Biohazards Committee 
Robert M. Neer, M.D., Chairman 
Melvin Chalfen, M.D., Commissioner 
of Health 
Oliver E. Farnum 
Elsa Stern 
Zelia Kelleher 
bkm 
( 606 ] 
